{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:13:03Z","timestamp":1787940783834,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023-MS-155"],"award-info":[{"award-number":["2023-MS-155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijgc.2024.100046","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T04:43:28Z","timestamp":1735620208000},"page":"100046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ovarian-stimulating drug use and risk of ovarian tumor in infertile women: a meta-analysis"],"prefix":"10.1016","volume":"35","author":[{"given":"Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijgc.2024.100046_bib1","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1093\/humrep\/dei253","article-title":"Complications of IVF and ovulation induction","volume":"20","author":"Klemetti","year":"2005","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.ijgc.2024.100046_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumors in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100046_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0015-0282(97)81431-8","article-title":"Infertility, fertility drugs, and invasive ovarian cancer: a case-control study","volume":"67","author":"Mosgaard","year":"1997","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.ijgc.2024.100046_bib4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijgc.2024.100046_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ijgc.2024.100046_bib6","series-title":"3rd Symposium on Systematic Reviews: Beyond the Basics","first-page":"3","article-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analyses","author":"Wells","year":"2000"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100046_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.ijgc.2024.100046_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"4","key":"10.1016\/j.ijgc.2024.100046_bib9","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ijgc.2024.100046_bib10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"7109","key":"10.1016\/j.ijgc.2024.100046_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ijgc.2024.100046_bib12","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.fertnstert.2013.02.010","article-title":"Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study","volume":"99","author":"Asante","year":"2013","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.ijgc.2024.100046_bib13","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/1055-9965.EPI-12-0426","article-title":"Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study","volume":"21","author":"Kurta","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100046_bib14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1055-9965.EPI-16-0809","article-title":"Cancer risk in women treated with fertility drugs according to parity status-a registry-based cohort study","volume":"26","author":"Reigstad","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.ijgc.2024.100046_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/aje\/kwn318","article-title":"Cancer risk after exposure to treatments for ovulation induction","volume":"169","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.ijgc.2024.100046_bib16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/aje\/kwh315","article-title":"A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs","volume":"160","author":"Rossing","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.ijgc.2024.100046_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/gyno.1997.4928","article-title":"Treatment for fertility and risk of ovarian tumors of borderline malignancy","volume":"68","author":"Parazzini","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100046_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/humrep\/deu297","article-title":"Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study","volume":"30","author":"Bj\u00f8rnholt","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ijgc.2024.100046_bib19","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/humrep\/17.8.2209","article-title":"Cancer incidence following treatment for infertility at a clinic in the UK","volume":"17","author":"Doyle","year":"2002","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.ijgc.2024.100046_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.humrep.a138771","article-title":"Fertility drugs and risk of epithelial ovarian cancer in Italy","volume":"9","author":"Franceschi","year":"1994","journal-title":"Hum Reprod"},{"issue":"10","key":"10.1016\/j.ijgc.2024.100046_bib21","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/humrep\/12.10.2159","article-title":"Treatment for infertility and risk of invasive epithelial ovarian cancer","volume":"12","author":"Parazzini","year":"1997","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.ijgc.2024.100046_bib22","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/humrep\/16.7.1372","article-title":"Use of fertility drugs and risk of ovarian cancer","volume":"16","author":"Parazzini","year":"2001","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.ijgc.2024.100046_bib23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.fertnstert.2015.11.034","article-title":"Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation","volume":"105","author":"Gronwald","year":"2016","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100046_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.fertnstert.2015.07.1135","article-title":"Cancer in women after assisted reproductive technology","volume":"104","author":"Luke","year":"2015","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100046_bib25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0015-0282(98)00337-9","article-title":"Ovarian stimulation and borderline ovarian tumors: a case-control study","volume":"70","author":"Mosgaard","year":"1998","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100046_bib26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2015.02.011","article-title":"Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers","volume":"103","author":"Perri","year":"2015","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ijgc.2024.100046_bib27","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.fertnstert.2008.01.073","article-title":"Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden","volume":"91","author":"Sanner","year":"2009","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100046_bib28","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.fertnstert.2013.08.008","article-title":"Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort","volume":"100","author":"Trabert","year":"2013","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.ijgc.2024.100046_bib29","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","article-title":"Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort","volume":"100","author":"Silva","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijgc.2024.100046_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b249","article-title":"Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study","volume":"338","author":"Jensen","year":"2009","journal-title":"BMJ"},{"issue":"8981","key":"10.1016\/j.ijgc.2024.100046_bib31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(95)91687-3","article-title":"Breast and ovarian cancer incidence after infertility and in vitro fertilisation","volume":"346","author":"Venn","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ijgc.2024.100046_bib32","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/humrep\/der322","article-title":"Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort","volume":"26","author":"van Leeuwen","year":"2011","journal-title":"Human reproduction (Oxford, England)"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100046_bib33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.fertnstert.2012.12.029","article-title":"In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services","volume":"99","author":"Brinton","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ijgc.2024.100046_bib34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/humrep\/des031","article-title":"Cancer morbidity in a cohort of 9175 Finnish women treated for infertility","volume":"27","author":"Yli-Kuha","year":"2012","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.ijgc.2024.100046_bib35","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/humrep\/dev124","article-title":"Cancer risk among parous women following assisted reproductive technology","volume":"30","author":"Reigstad","year":"2015","journal-title":"Hum Reprod"},{"issue":"11","key":"10.1016\/j.ijgc.2024.100046_bib36","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/oxfordjournals.aje.a009397","article-title":"Cancer incidence in a cohort of infertile women","volume":"147","author":"Modan","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.ijgc.2024.100046_bib37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0015-0282(99)00085-0","article-title":"Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study","volume":"71","author":"Potashnik","year":"1999","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100046_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(01)02986-7","article-title":"Cancer incidence in a cohort of infertile women who underwent in vitro fertilization","volume":"77","author":"Dor","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100046_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00432-015-2035-x","article-title":"The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up","volume":"142","author":"Kessous","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2024.100046_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","article-title":"In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk","volume":"128","author":"Stewart","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100046_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/humrep\/deq307","article-title":"Malignancies among women who gave birth after in vitro fertilization","volume":"26","author":"K\u00e4ll\u00e9n","year":"2011","journal-title":"Hum Reprod"},{"issue":"9190","key":"10.1016\/j.ijgc.2024.100046_bib42","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","article-title":"Risk of cancer after use of fertility drugs with in-vitro fertilisation","volume":"354","author":"Venn","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100046_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ijgc-00009577-200301000-00004","article-title":"The possible association between in vitro fertilization treatments and cancer development","volume":"13","author":"Lerner-Geva","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.ijgc.2024.100046_bib44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/09513590.2012.671391","article-title":"Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up","volume":"28","author":"Lerner-Geva","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.ijgc.2024.100046_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(16)58020-0","article-title":"Human menopausal gonadotropin and the risk of epithelial ovarian cancer","volume":"65","author":"Shushan","year":"1996","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ijgc.2024.100046_bib46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.rbmo.2019.11.015","article-title":"Cancer in IVF patients treated at age 40 years and older: long term follow-up","volume":"40","author":"Tsafrir","year":"2020","journal-title":"Reprod Biomed Online"},{"issue":"11","key":"10.1016\/j.ijgc.2024.100046_bib47","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/humrep\/dez165","article-title":"Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study","volume":"34","author":"Vassard","year":"2019","journal-title":"Hum Reprod"},{"issue":"11","key":"10.1016\/j.ijgc.2024.100046_bib48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10654-019-00540-3","article-title":"Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study","volume":"34","author":"Lundberg","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"10.1016\/j.ijgc.2024.100046_bib49","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/djaa163","article-title":"Long-term risk of ovarian cancer and borderline tumors after assisted reproductive technology","volume":"113","author":"Spaan","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijgc.2024.100046_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fendo.2019.00313","article-title":"Do the fertility drugs increase the risk of cancer? A review study","volume":"10","author":"Momenimovahed","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ijgc.2024.100046_bib51","first-page":"CD008215","article-title":"Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility","volume":"6","author":"Rizzuto","year":"2019","journal-title":"Cochrane Database Syst Rev"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24030421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24030421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T02:39:28Z","timestamp":1769913568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24030421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1048891X24030421"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2024.100046","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian-stimulating drug use and risk of ovarian tumor in infertile women: a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2024.100046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"100046"}}